Reference health

Cancer-Associated Fibroblast Mediated Inhibition of CD8+ Cytotoxic T Cell Accumulation in Tumours: Mechanisms and Therapeutic Opportunities

https://doi.org/10.3390/cancers12092687

98/98 checkable references clean · checked 2026-07-23

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 98 checked references that resolve

resolves10.1038/onc.2008.271

The tumor microenvironment and its role in promoting tumor growth

resolves10.1101/732149

Blockade of stromal Gas6 alters cancer cell plasticity, activates NK cells and inhibits pancreatic cancer metastasis

resolves10.1158/0008-5472.CAN-16-1201

Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors

resolves10.1038/s41388-017-0115-x

Blockade of insulin-like growth factors increases efficacy of paclitaxel in metastatic breast cancer

resolves10.1158/0008-5472.CAN-17-3876

Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer

resolves10.3389/fimmu.2018.01132

Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma

resolves10.1038/ncb3340

Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis

resolves10.1101/gad.279737.116

Carcinoma-associated fibroblasts: orchestrating the composition of malignancy

resolves10.1038/nrc.2016.73

The biology and function of fibroblasts in cancer

resolves10.1038/nri3902

Immunological hallmarks of stromal cells in the tumour microenvironment

resolves10.3390/cancers7040902

Cancer-Associated Fibroblasts: Their Characteristics and Their Roles in Tumor Growth

resolves10.1002/jcb.27703

Cancer‐associated fibroblasts: Secretions, interactions, and therapy

resolves10.4161/cc.8.23.10238

The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

resolves10.1016/j.cmet.2018.09.012

Tumor-Stroma Mechanics Coordinate Amino Acid Availability to Sustain Tumor Growth and Malignancy

resolves10.1038/s41467-018-05220-6

Targeting stromal remodeling and cancer stem cell plasticity overcomes chemoresistance in triple negative breast cancer

resolves10.3389/fimmu.2019.01835

The Dark Side of Fibroblasts: Cancer-Associated Fibroblasts as Mediators of Immunosuppression in the Tumor Microenvironment

resolves10.3389/fimmu.2018.00414

Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts

resolves10.1016/j.ccr.2014.04.005

Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival

resolves10.1016/j.ccr.2014.04.021

Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma

resolves10.1172/jci.insight.92232

Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma

resolves10.1126/science.1195300

Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein–α

resolves10.1084/jem.20122344

Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia

resolves10.1038/s41568-019-0238-1

A framework for advancing our understanding of cancer-associated fibroblasts

resolves10.1038/nature13954

PD-1 blockade induces responses by inhibiting adaptive immune resistance

resolves10.1038/s41591-018-0136-1

Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response

resolves10.1016/j.immuni.2013.07.012

Oncology Meets Immunology: The Cancer-Immunity Cycle

resolves10.1016/j.ccell.2018.01.011

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer

resolves10.1053/j.gastro.2013.07.025

Activated Pancreatic Stellate Cells Sequester CD8+ T Cells to Reduce Their Infiltration of the Juxtatumoral Compartment of Pancreatic Ductal Adenocarcinoma

resolves10.1073/pnas.1320318110

Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancer

resolves10.15252/embj.2019104063

Stromal cell diversity associated with immune evasion in human triple‐negative breast cancer

resolves10.1073/pnas.1908626116

Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells

resolves10.1007/s10585-019-09966-1

The extracellular matrix in tumor progression and metastasis

resolves10.1006/scbi.1995.0017

Involvement of extracellular matrix constituents in breast cancer

resolves10.1172/JCI45817

Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors

resolves10.3389/fimmu.2015.00500

Real-Time Imaging of Resident T Cells in Human Lung and Ovarian Carcinomas Reveals How Different Tumor Microenvironments Control T Lymphocyte Migration

resolves10.1038/nm.4123

Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy

resolves10.1158/1078-0432.CCR-13-2972

Prevailing Role of Contact Guidance in Intrastromal T-cell Trapping in Human Pancreatic Cancer

resolves10.1186/s40425-019-0556-6

Collagen density regulates the activity of tumor-infiltrating T cells

resolves10.1038/ncomms15095

Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer

resolves10.18632/oncotarget.10038

Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma

resolves10.1245/s10434-014-4149-9

Histologic Categorization of Desmoplastic Reaction: Its Relevance to the Colorectal Cancer Microenvironment and Prognosis

resolves10.1038/nature25501

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

resolves10.1038/nature25492

TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis

resolves10.3389/fmolb.2019.00160

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

resolves10.1186/bcr3458

HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs)

resolves10.3389/fonc.2013.00231

Ways to Enhance Lymphocyte Trafficking into Tumors and Fitness of Tumor Infiltrating Lymphocytes

resolves10.1172/JCI96268

Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy

resolves10.1186/s12943-019-1089-9

Role of hypoxia in cancer therapy by regulating the tumor microenvironment

resolves10.3389/fonc.2018.00189

Hypoxic Signalling in Tumour Stroma

resolves10.1038/s41389-017-0011-9

The hypoxic tumour microenvironment

resolves10.1016/j.immuni.2016.04.017

Co-stimulatory and Co-inhibitory Pathways in Autoimmunity

resolves10.1172/JCI46102

Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients

resolves10.1073/pnas.1003345107

Tumor-infiltrating NY-ESO-1–specific CD8 + T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer

resolves10.1084/jem.20160801

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity

resolves10.1016/j.cellimm.2017.01.001

Tumor antigen-specific CD8+ T cells are negatively regulated by PD-1 and Tim-3 in human gastric cancer

resolves10.1093/bfgp/ely006

CD8+ T-cell exhaustion in cancer: mechanisms and new area for cancer immunotherapy

resolves10.1158/1078-0432.CCR-12-1632

Oncogenic BRAF(V600E) Promotes Stromal Cell-Mediated Immunosuppression Via Induction of Interleukin-1 in Melanoma

resolves10.3389/fimmu.2019.00847

Human Pancreatic Carcinoma-Associated Fibroblasts Promote Expression of Co-inhibitory Markers on CD4+ and CD8+ T-Cells

resolves10.1038/s41598-017-08479-9

Prognostic value of programmed cell death protein 1 expression on CD8+ T lymphocytes in pancreatic cancer

resolves10.1038/s41467-018-03347-0

Cancer-associated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells

resolves10.1002/ijc.32278

Cancer‐associated fibroblasts promote PD‐L1 expression in mice cancer cells via secreting CXCL5

resolves10.1038/s41419-018-0458-4

Cancer-associated fibroblasts induce PDL1+ neutrophils through the IL6-STAT3 pathway that foster immune suppression in hepatocellular carcinoma

resolves10.1158/0008-5472.CAN-19-0960

Deoxycytidine Release from Pancreatic Stellate Cells Promotes Gemcitabine Resistance

resolves10.1155/2018/6075403

Metabolic Reprogramming of Cancer Associated Fibroblasts: The Slavery of Stromal Fibroblasts

resolves10.3390/cancers11050619

Fibroblasts as Modulators of Local and Systemic Cancer Metabolism

resolves10.1186/s12967-016-1057-8

Mesenchymal stromal cells derived from cervical cancer produce high amounts of adenosine to suppress cytotoxic T lymphocyte functions

resolves10.1016/j.ccr.2011.01.020

Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth

resolves10.1084/jem.20180818

Bone marrow–derived fibroblasts are a functionally distinct stromal cell population in breast cancer

resolves10.1186/s13045-019-0770-1

Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy

resolves10.1186/s40425-018-0360-8

Targeting adenosine for cancer immunotherapy

resolves10.1038/s41388-019-0688-7

Lactate modulates CD4+ T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8/miR21 axis

resolves10.1182/blood-2006-07-035972

Inhibitory effect of tumor cell–derived lactic acid on human T cells

resolves10.1158/0008-5472.CAN-11-1272

Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes

resolves10.1002/ijc.26410

Tumor lactic acidosis suppresses CTL function by inhibition of p38 and JNK/c‐Jun activation

resolves10.1371/journal.pbio.1002202

Lactate Regulates Metabolic and Pro-inflammatory Circuits in Control of T Cell Migration and Effector Functions

resolves10.1371/journal.pone.0055146

Arginase II Expressed in Cancer-Associated Fibroblasts Indicates Tissue Hypoxia and Predicts Poor Outcome in Patients with Pancreatic Cancer

resolves10.1111/j.1476-5381.2009.00291.x

Arginase: an emerging key player in the mammalian immune system

resolves10.1038/oncsis.2016.7

Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation

resolves10.4049/jimmunol.1000896

Reciprocal Functional Modulation of the Activation of T Lymphocytes and Fibroblasts Derived from Human Solid Tumors

resolves10.1136/gutjnl-2018-317570

Stromal protein βig-h3 reprogrammes tumour microenvironment in pancreatic cancer

resolves10.2337/db15-0638

βig-h3 Represses T-Cell Activation in Type 1 Diabetes

resolves10.1158/2159-8290.CD-19-0094

Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts

resolves10.1084/jem.168.4.1457

A novel activation pathway for mature thymocytes. Costimulation of CD2 (T,p50) and CD28 (T,p44) induces autocrine interleukin 2/interleukin 2 receptor-mediated cell proliferation.

resolves10.1158/1078-0432.CCR-11-3216

The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the Literature

resolves10.1002/jso.25091

Prognostic value of intra‐tumoral CD8+/FoxP3+ lymphocyte ratio in patients with resected colorectal cancer liver metastasis

resolves10.1186/s12967-018-1460-4

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer

resolves10.1016/j.ejca.2018.12.011

Neoepitopes-based vaccines: challenges and perspectives

resolves10.1038/s41577-020-0306-5

A guide to cancer immunotherapy: from T cell basic science to clinical practice

resolves10.1002/ajh.25108

Potent anti‐leukemia activities of humanized CD19‐targeted Chimeric antigen receptor T (CAR‐T) cells in patients with relapsed/refractory acute lymphoblastic leukemia

resolves10.1038/nm.4441

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy

resolves10.1158/0008-5472.CAN-18-0118

Combined Blockade of IL6 and PD-1/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment

resolves10.1158/2326-6066.CIR-16-0303

Increasing Tumor-Infiltrating T Cells through Inhibition of CXCL12 with NOX-A12 Synergizes with PD-1 Blockade

resolves10.4049/jimmunol.1502376

Chemoattractant Receptors BLT1 and CXCR3 Regulate Antitumor Immunity by Facilitating CD8+ T Cell Migration into Tumors

resolves10.1158/0008-5472.CAN-08-2281

Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment

resolves10.1158/0008-5472.CAN-11-1466

Chemotherapy Induces Intratumoral Expression of Chemokines in Cutaneous Melanoma, Favoring T-cell Infiltration and Tumor Control

resolves10.1038/ncomms8458

Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints

resolves10.1093/jnci/djx121

Targeting the Myofibroblastic Cancer-Associated Fibroblast Phenotype Through Inhibition of NOX4

resolves10.1158/0008-5472.CAN-19-3158

NOX4 Inhibition Potentiates Immunotherapy by Overcoming Cancer-Associated Fibroblast-Mediated CD8 T-cell Exclusion from Tumors

The 2 references without a DOI — listed, not checked

no DOI — not checkedMammary Fibroblasts May Influence Breast Tumor Angiogenesis via Hypoxia-induced Vascular Endothelial Growth Factor Up-Regulation and Protein Expression

no DOI — not checkedThe Checkpoint Immunotherapy Revolution: What Started as a Trickle Has Become a Flood, Despite Some Daunting Adverse Effects; New Drugs, Indications, and Combinations Continue to Emerge

What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-23 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.3390/cancers12092687"><img src="https://citestamp.com/citestamped/10.3390/cancers12092687/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>

[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.3390/cancers12092687/badge.svg)](https://citestamp.com/citestamped/10.3390/cancers12092687)